Skip to content
10-K

Annual Report

BLUEPRINT MEDICINES CORPORATION

0001558370-25-000953

← back to feed
Filed
Feb 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 11, 2025 63.91M sh
Stock Issued FY 2024 · Dec 31, 2024 544.72K sh
Stock Issued FY 2024 · Dec 31, 2023 0 sh
Stock Issued FY 2024 · Dec 31, 2022 0 sh
Shares Diluted FY 2024 · Dec 31, 2024 62.86M sh
Shares Diluted FY 2024 · Dec 31, 2023 60.56M sh
Shares Diluted FY 2024 · Dec 31, 2022 59.64M sh
Capex FY 2024 · Dec 31, 2024 $4.63M
Capex FY 2024 · Dec 31, 2023 $16.06M
Capex FY 2024 · Dec 31, 2022 $8.92M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$192.59M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$436.85M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$502.28M
Cash And Equivalents FY 2024 · Dec 31, 2024 $102.01M
Cash And Equivalents FY 2024 · Dec 31, 2023 $71.29M
Cash And Equivalents FY 2024 · Dec 31, 2022 $119.71M
Stockholders Equity FY 2024 · Dec 31, 2024 $298.67M
Stockholders Equity FY 2024 · Dec 31, 2023 $130.61M
Current Liabilities FY 2024 · Dec 31, 2024 $260.8M
Current Liabilities FY 2024 · Dec 31, 2023 $214.92M
Total Liabilities FY 2024 · Dec 31, 2024 $881.15M
Total Liabilities FY 2024 · Dec 31, 2023 $918.64M
Current Assets FY 2024 · Dec 31, 2024 $742.68M
Current Assets FY 2024 · Dec 31, 2023 $808.39M
Total Assets FY 2024 · Dec 31, 2024 $1.18B
Total Assets FY 2024 · Dec 31, 2023 $1.05B
Eps Diluted FY 2024 · Dec 31, 2024 −$1.07
Eps Diluted FY 2024 · Dec 31, 2023 −$8.37
Eps Diluted FY 2024 · Dec 31, 2022 −$9.35
Eps Basic FY 2024 · Dec 31, 2024 −$1.07
Eps Basic FY 2024 · Dec 31, 2023 −$8.37
Eps Basic FY 2024 · Dec 31, 2022 −$9.35
Sga Expense FY 2024 · Dec 31, 2024 $359.27M
Sga Expense FY 2024 · Dec 31, 2023 $295.14M
Sga Expense FY 2024 · Dec 31, 2022 $237.37M
Rd Expense FY 2024 · Dec 31, 2024 $341.43M
Rd Expense FY 2024 · Dec 31, 2023 $427.72M
Rd Expense FY 2024 · Dec 31, 2022 $477.42M
Net Income FY 2024 · Dec 31, 2024 −$67.09M
Net Income FY 2024 · Dec 31, 2023 −$506.98M
Net Income FY 2024 · Dec 31, 2022 −$557.52M
Cost Of Revenue FY 2024 · Dec 31, 2024 $20.16M
Cost Of Revenue FY 2024 · Dec 31, 2023 $8.54M
Cost Of Revenue FY 2024 · Dec 31, 2022 $17.81M